Maxim Group analyst Naz Rahman reiterated a Buy rating on Palisade Bio (PALI – Research Report) yesterday. The company’s shares opened today at $0.70. Easily identify stocks' risks and ...

Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after its Q4 results. The firm expects the benefits from ...

Maxim analyst Naz Rahman downgraded Galmed (GLMD) to Hold from Buy. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter ...

Maxim Group analyst Naz Rahman reiterated a Buy rating on NexGel Inc yesterday and set a price target of $6.00. The company’s shares closed last Tuesday at $3.03. According to TipRanks.com ...

Detailed price information for Palisade Bio Inc (PALI-Q) from The Globe and Mail including charting and trades.